SCHEMBL7140968

SCHEMBL7140968

CC(C)(C)OC(=O)COc1cc(NC(=O)OC(C)(C)C)c(NC(=O)CC(=O)c2cccc(-n3ccnc3)c2)cc1-c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
PORCN Q9H237 1/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
KDM4D Q6B0I6 1/20 0.34
CYP17A1 P05093 2/20 0.33
ADH5 P11766 2/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KCNQ4 P56696 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147242 0.92 ABL1 (0.41) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7139934 0.92 ABL1 (0.41) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7145881 0.91 ABL1 (0.39) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7145856 0.91 ABL1 (0.38) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7141902 0.90 ABL1 (0.37) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7146597 0.89 ADH5 (0.41) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7143394 0.88 ADH5 (0.40) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL5868843 0.86 CYP17A1 (0.42) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7139808 0.86 ABL1 (0.39) ABL1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL7141809 0.83 ABL1 (0.40) ABL1L3MBTL1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed